Thus, the simultaneous inhibition of MAO-B, as well as AChE enzymatic activity represents an innovative therapeutic weapon [8] and multifunctional molecules able to reduce radicals’ formation and to tackle ACh decrease may be beneficial to hamper the neurotoxic cascade in AD. The gene discussed is ACHE; the disease is Alzheimer disease.